It should also be noted that rare genetic variations in ECS, including the genes CNR1 and CNR2 encoding CB1R and CB2R, respectively, as well as the genes for the degrading enzymes DAGLA, MGLL, and FAAH have been reported in patients with neurological disorders [291]. This evidence concerns the gene FAAH and nervous system disorder.